Health Care·Health Care Services·$21.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.06 | N/A | -2.48% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.06 | N/A | -2.48% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about current market conditions and their impact on performance. They highlighted efforts to improve efficiency.
Management acknowledged the challenging environment impacting results.
They emphasized a focus on operational efficiency moving forward.
This earnings report indicates that Quest Diagnostics faced challenges, resulting in a slight miss on EPS. The stock reacted negatively, declining by 1.49%. Investors may be cautious as management did not provide guidance, reflecting uncertainty in the current market environment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
JOHNSON & JOHNSON
Jul 16, 2013